Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 56.00
-0.50 (-0.88%)
At close: Sep 10, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.36 billion as of September 11, 2026. Its market cap has decreased by -41.25% in one year.
Market Cap
2.36B
Enterprise Value
2.24B
Revenue
265.54M
Ranking
n/a
PE Ratio
109.68
Stock Price
56.00
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.36B, an increase of 69.19%. That is a compound annual growth rate of 28.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.36B | -34.29% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 19.66B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.73B |
| Intelligene | 8.21B |
| Uwell Biopharma | 7.32B |
| Obigen Pharma | 5.28B |
| Tripartite Therapeutics | 4.96B |
| BIONET Therapeutics | 2.47B |
| FullHope Biomedical | 1.33B |